ArticleFood science & nutrition2026
Development of a High-Sensitivity Electrochemical Biosensor for Domoic Acid and Its Cellular Impact on Human Stem and Neuron-Like Cells.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Domoic acid (DA) is an important environmental neurotoxin produced by certain types of marine algae and can accumulate in seafood such as anchovies, sardines, and mussels, which are considered healthy and widely consumed globally. One of the most important issues to consider is taking necessary measures to prevent water and marine pollution and conducting proper safety controls before consuming seafood. This study aimed to develop a high-sensitivity electrochemical biosensor system for detecting DA in seafood, aiding marine pollution monitoring. Additionally, the cytotoxicity of DA at the highest Food & Drug Administration (FDA)-permitted concentration and the concentrations determined in this study was examined on human cells. Gene expression related to cytotoxic response, DNA repair, and neurotoxicity was analyzed using amniotic fluid-derived mesenchymal stem cells (hAF-MSCs) and the human neuroblastoma cell line (SH-SY5Y) as neuron-like cell models. DA did not significantly affect the viability of hAF-MSCs or SH-SY5Y cells at 48-h exposure but slightly reduced viability at 100 μg/mL compared to the control group. DA activated the glutamate receptor in hAF-MSCs but not in SH-SY5Y cells. It also reduced DNA repair capacity in hAF-MSCs, though effects on viability and proliferation likely did not manifest within 48 h. There was no change in gene expression at 75 ng/mL of DA, which indicated the tolerable daily intake set by the FDA. The SH-SY5Y cells exhibited resistance against DA, indicating enhanced their DNA repair to prevent themselves against apoptosis and cell death. It is also supported by the upregulation of DNA repair-related genes and the membrane transporter gene ABCG2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.